Critical prospective appraisal of renal morphology and function in children undergoing shockwave lithotripsy and percutaneous nephrolithotomy

PURPOSE: To assess the effect of shockwave lithotripsy (SWL) and percutaneous nephrolithotomy (PCNL) on renal morphology and function in children undergoing therapy for upper-tract urolithiasis. PATIENTS AND METHODS: Fourteen patients less than 13 years of age with renal or upper-ureteral calculi who were found suitable for primary SWL or PCNL were evaluated for alteration of renal morphology and function after treatment. Of the 18 renal units treated, SWL and PCNL were performed in 9 units each. The average stone size was 880.2 mm2 (range 110-3800 mm2; median 660 mm2). All children underwent ultrasonic estimation of renal length and parenchymal thickness, 99m technetium dimercaptosuccinic acid (DMSA) and 99m Tc-ethylene dicystine (EDC) scintigraphy, and glomerular filtration rate (GFR) estimation prior to intervention and at 3 and 6 months of follow-up. RESULTS: Extracorporeal lithotripsy achieved complete clearance in 8 renal units (88%), requiring an average of 6333 shockwaves and an average of 2.2 sessions per renal unit. The efficiency quotient was 42. Percutaneous surgery likewise achieved complete stone clearance in 88% of renal units, with three units requiring more than one tract. Mixed calcium oxalate monohydrate and dihydrate accounted for the majority of the stones. The mean preintervention GFR was 78.3 +/- 14.6 mL/min/1.73 m2 (median 82.5 mL/min/1.73 m2; range 54-98.6 mL/min/1.73 m2), whereas the mean GFR at 3 months was 78.95 +/- 14.4 mL/min/1.73 m2 (median 78.95 mL/min/1.73 m2; range 52-98 mL/min/1.73 m2). A marginal improvement of an average of 0.65 mL/min was noted. Split function EDC scans demonstrated improved drainage in five cases after intervention; the rest were unchanged. Preintervention DMSA scans revealed renal cortical scars in three children. None of the renal units had developed fresh scars at follow-up scans. None of the children developed new-onset hypertension, proteinuria, or alteration in renal size. CONCLUSION: In the present study, pediatric SWL and PCNL were not found to cause adverse renal morphologic or functional alteration. Stone clearance resulted in marginally improved function and better drainage.     

Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre

OBJECTIVE: To review our experience of percutaneous nephrolithotomy (PCNL) in children before school age, and determine its efficacy and safety in this age group. PATIENTS AND METHODS: The records of children aged < or = 5 years undergoing PCNL were reviewed. Variables assessed included stone number, size, location and type. The PCNL puncture site and number were also recorded. We reviewed stone clearance with PCNL, ancillary procedures used, complication rates and follow-up status of the children. RESULTS: There were 30 renal units in 29 children (median age 3.8 years, range 1.4-5). Because of poor growth the mean (SD) body weight of the children was only 12.2 (2.8) kg, which is near the 50th percentile for children of mean age 3.5 years. The median (range) stone burden was 2.35 (1.3-6) cm; 60% of the patients had single stones while 28% had more than five. There were five staghorn stones. All PCNL was primary and with one puncture, using a 17 F angled nephroscope; stones were fragmented using a pneumatic lithoclast. After PCNL stones were completely cleared in 60% of the renal units, which increased to 100% after combining it with extracorporeal shockwave lithotripsy. The median (range) follow-up was 24.9 (4-51) months; the overall complication rate was 6%. In the long follow-up hypertension was not detected in any child and isotopic renograms in 17 kidneys detected no new scarring or loss of renal function. CONCLUSION: PCNL is a safe and effective for treating renal stones in very young children.     

Combination of laparoscopy and nephroscopy for treatment of stones in pelvic ectopic kidneys

PURPOSE: To present the combination of laparoscopy and nephroscopy for the treatment of stones in pelvic ectopic kidneys. PATIENTS AND METHODS: The series included seven male and four female patients (mean age 43 +/- 9 years). Laparoscopy-assisted percutaneous nephrolithotomy (PCNL) was performed for caliceal stones in five patients after failure of shockwave lithotripsy, while laparoscopic pyelolithotomy was performed for large or branched renal pelvic stones in six patients. RESULTS: The mean operative time was 164 +/- 30 minutes. There were neither complications nor conversions to open surgery. The stone-free rate was 91% (10 patients). One patient had a residual caliceal fragment that was treated with shockwave lithotripsy. The mean hospital stay was 3.5 +/- 0.7 days. CONCLUSION: The combination of laparoscopy and nephroscopy is feasible, safe, and effective for the treatment of stones in pelvic kidneys.     

Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy

PURPOSE: We compared the results of percutaneous nephrolithotomy and shock wave lithotripsy for the treatment of 1 to 2 cm renal stones in children. MATERIALS AND METHODS: The study included 166 children with renal stones 1 to 2 cm. A total of 75 patients (82 kidneys) were treated with percutaneous nephrolithotomy and 91 (93 kidneys) were treated with shock wave lithotripsy. Mean followup was 31 +/- 10 months (range 6 to 84). Both groups were compared regarding stone-free rate, re-treatment rate, complications and incidence of stone recurrence. RESULTS: Both groups were comparable regarding preoperative characteristics. Of the units treated with percutaneous nephrolithotomy 4 (4.9%) were associated with minor complications. Stone-free rate after a single session of percutaneous nephrolithotomy was 86.6% (71 units), and the remaining 11 kidneys with residual stones were successfully treated with repeat percutaneous nephrolithotomy in 7 and shock wave lithotripsy in 4. Therefore, a total of 78 units (95%) were stone-free after percutaneous nephrolithotomy monotherapy, and the overall stone-free rate at 3 months was 100%. Of the patients undergoing shock wave lithotripsy 1 (1.1%) had development of steinstrasse and was successfully treated with ureteroscopy. The overall re-treatment rate after shock wave lithotripsy was 55%. A total of 79 units (84.9%) were stone-free after shock wave lithotripsy monotherapy, whereas 7 (7.5%) with no gross response to treatment were treated with percutaneous nephrolithotomy and 7 with insignificant stones less than 4 mm were followed. Therefore, the overall stone-free rate at 3 months was 92.5%. The differences in stone-free rates and re-treatment rates significantly favored percutaneous nephrolithotomy, while the incidence of complications and stone recurrence at last followup were not significantly different between the groups. CONCLUSIONS: For treatment of 1 to 2 cm renal stones in children percutaneous nephrolithotomy is better than shock wave lithotripsy, yielding higher stone-free and lower re-treatment rates.     

Treatment of complete staghorn stones: a prospective randomized comparison of open surgery versus percutaneous nephrolithotomy

PURPOSE: We studied the role of open surgery versus percutaneous nephrolithotomy (PCNL) in the treatment of complete staghorn stones in a prospective randomized manner. MATERIALS AND METHODS: A total of 79 patients with 88 complete staghorn stones, defined as filling the entire collecting system or at least 80% of it, were prospectively randomized for PCNL (43) or open surgery (45). Intraoperative and postoperative morbidity, operative time, hospital stay, and stone clearance at discharge home and followup were compared for both methods. Patients with significant residuals in both groups were subjected to extracorporeal shock wave lithotripsy (Dornier Medical Systems, Inc., Marietta, Georgia) on an outpatient basis. Followup was completed for all cases with a mean duration +/- SD of 4.9 +/- 2.5 months (range 3 to 14). Renal function was evaluated by Tc-mercaptoacetyltriglycine renogram before and after treatment in both groups. RESULTS: Intraoperative complications in terms of bleeding requiring blood transfusion, and pleural, vascular or ureteral injuries were recorded in 7 patients (16.3%) in the PCNL and 17 (37.8%) in the open surgery groups, a difference of significant value (p <0.05). Major postoperative complications including massive hematuria requiring blood transfusion, septicemia, urinary leakage and wound infection were observed in 8 patients (18.6%) in the PCNL group and in 14 (31.1%) in the open surgery group, a difference of no significant value. PCNL was associated with shorter operative time (127 +/- 30 vs 204 +/- 31 minutes, p <0.001), shorter hospital stay (6.4 +/- 4.2 vs 10 +/- 4.2 days, p <0.001) and earlier return to work (2.5 +/- 0.8 vs 4.1 +/- 1 weeks, p <0.001). On the other hand both treatment groups were comparable in regard to stone-free rates at discharge home (49% vs 66%) and at followup (74% vs 82%). At followup renal function improved or remained stable in 91% and 86.7% in the PCNL and open surgery groups, respectively. CONCLUSIONS: PCNL is a valuable treatment option for complete staghorn stones with a stone-free rate approaching that of open surgery. Moreover, it has the advantages of lower morbidity, shorter operative time, shorter hospital stay and earlier return to work.     

经皮肾取石术在老年肾结石患者中的应用

目的探讨经皮肾取石术（percutaneous nephrolithotomy，PCNL）治疗老年肾结石的疗效及安全性。方法2005年1月-2011年12月对57例老年（年龄61—87岁，平均69岁）肾结石行PCNL。采用B超引导下建立经皮肾通道F16-F24，留置相应工作外鞘置入F8.0/9.8输尿管镜或F20.8经皮肾镜，钬激光或EMS碎石清系统碎石并清除结石。结果手术时间30～140min，平均65min。一期结石清除率78．9％（45／57）。1例术后体温〉38．5oC，经抗感染治疗后好转；2例术中、术后出血较多（分别出血1800、2500m1）给予输血治疗，其中1例因假性动脉瘤行肾动脉高选择性栓塞治疗好转。无一例损伤肝、脾等重要脏器及诱发呼吸和循环功能衰竭等其他严重并发症。12例结石残留者行二次PCNL4例及辅助ESWL5例，术后分别各有1例肾下盏少量结石残留，另7例无结石残留；5例结石残留随访6—24个月，除1例肾结石略有增大外其余4例无明显变化。46例结石清除者随访3—34个月，平均14．3月，除2例复发保守治疗外其余无复发。结论PCNL治疗老年肾结石安全，疗效满意。积极的术前准备、熟练的经皮肾镜技术及加强围手术期监测和管理是提高安全性的关键。     

经皮肾镜取石术联合套石网篮治疗 ESWL 排空障碍的输尿管上段结石合并肾盏结石

目的：探讨经皮肾镜取石术（ percutaneous nephrolithotomy , PCNL ）联合套石网篮治疗体外震波碎石（ extracorporeal shock wave lithotripsy ,ESWL）排空障碍的肾盏及输尿管上段结石的临床疗效。方法2009年4月～2012年8月采用PCNL联合套石网篮治疗ESWL排空障碍的输尿管上段结石合并肾盏结石78例。 B超定位,58例肾盏结石长径＜1 cm或分布于单组肾盏,采用微通道经皮肾镜下气压弹道碎石;20例肾盏结石长径＞1 cm或分布于多组肾盏采用新型经皮肾镜标准通道下气压弹道或超声联合气压弹道碎石。结果78例手术均获成功,手术时间52～98 min,平均61 min。71例一期取净结石,结石取净率91．0％（71/78）;2例二期碎石后取净;3例辅助行ESWL治疗;2例因残留结石较小药物排石排出。住院5～12 d,平均7．2 d。无胸膜及其他重要脏器损伤,无大出血等严重并发症。78例随访3个月,未见结石残留。结论PCNL术中联合套石网篮可减少皮肾穿刺通道数,避免大出血及集合系统狭窄风险,是处理ESWL排空障碍的肾盏及输尿管上段结石恰当的选择。     

超声联合气压弹道碎石术治疗复杂性肾结石(附78例报道)

目的:探讨经皮肾镜下超声联合气压弹道碎石术治疗复杂性肾结石的方法及疗效。方法:B超引导下穿刺并扩张建立F22经皮肾镜操作通道,在F20.8肾镜下采用瑞士第三代EMS超声气压弹道碎石机,争取一期粉碎结石并主动吸出体外。结果:78例83侧肾结石,单侧结石清除时间43~156min,平均89min。结石粉碎率100%,结石取净率85.6%(71/83)。术后随访1~9个月,平均5.6个月,均无严重并发症如出血及感染,亦无结石复发。结论:经皮肾镜超声联合气压弹道碎石术可以明显地提高复杂性肾结石取石的效率,降低结石的残余率,具有高效、安全、微创的特点,有较好的推广应用价值。     

移植肾尿路结石46例诊治体会

目的探讨肾移植术后尿路结石的诊断和治疗,提高长期存活率。方法回顾性分析1980年1月至2011年6月46例移植肾结石患者的临床资料。结果 35例为肉眼血尿,10例为体检时B超发现,1例为急性无尿发病,均无肾绞痛。移植肾结石24例,移植输尿管结石22例,结石大小0.7～2.0 cm,结石发病时间为术后3.5（0.4～15）年。42例行体外冲击波碎石（ES-WL）,其中3例无效行输尿管镜下钬激光碎石术和1例行经皮肾镜取石术（PCNL）,4例尿酸结石给予枸橼酸氢钾钠（友来特）药物治疗。随访3个月：42例ESWL中,结石排净36例（85.72%）,结石残留2例（4.76%）,4例（9.52%）无效改用腔镜治疗后结石排出;4例尿酸结石口服枸橼酸氢钾钠结石大部分排出。结论移植肾结石缺乏典型肾绞痛表现,体外冲击波碎石术是治疗移植肾结石安全、有效的主要方法。     

Impact of temporary hilar clamping during laparoscopic partial nephrectomy on postoperative renal function: a prospective study

PURPOSE: Laparoscopic partial nephrectomy for small renal tumors has been increasingly performed in the last few years. We prospectively evaluated preoperative and postoperative differential renal function by renal scan in patients with contralaterally functioning kidneys who underwent laparoscopic partial nephrectomy with hilar clamping. MATERIALS AND METHODS: From July 2002 to June 2003, 17 consecutive patients were included in this prospective protocol and underwent laparoscopic partial nephrectomy for exophytic tumors using en bloc hilar clamping. Preoperative renal scan with differential function was performed 1 month before and 3 months after surgery in all patients. technetium labeled diethylenetetraminepentaacetic acid scan was performed in all patients. RESULTS: Mean warm ischemia time was 22.50 +/- 9.78 minutes (range 10 to 44). Preoperative differential renal function and glomerular filtration rate (GFR) in the affected kidneys were 50.20% +/- 4.90% (range 43 to 58) and 75.56 +/- 16.45 ml per minutes (range 39.4 to 105). At postoperative month 3 differential renal function and GFR in the affected kidney were 48.07% +/- 7.16% (range 39% to 63%) and 72.03 +/- 18.17 ml per minutes (range 31 to 101). There was a nonsignificant negative association between hilar clamp time and change in renal function (postoperative - preoperative) of the affected kidney (r = -0.26, p = 0.31), and a positive correlation between clamp time and change in GFR (r = 0.39, p = 0.12) that did not reach statistical significance. CONCLUSIONS: In patients with contralaterally functioning kidney, temporary hilar clamping with a mean warm ischemia time of 22.5 minutes results in preservation of renal function in the affected kidney. Larger studies with longer followup are necessary to study the impact of warm ischemia further.     

Quantitative Evaluation of Renal Parenchymal Mass With sup 99m Technetium Dimercapto-Succinic Acid Scintigraphy After Nephrolithotomy

Purpose

We detected renal parenchymal damage after nephrolithotomy.

Materials and Methods

We studied 12 patients with renal stones treated with nephrolithotomy. Renal function was determined with serum blood urea nitrogen (BUN) and creatinine values, and ^99mtechnetium dimercapto-succinic acid scintigraphy of renal parenchymal tissue was performed before, and 7 days and 3 months after nephrolithotomy. Qualitative and quantitative analyses were done with the Wilcoxon signed rank test.

Results

There was no visual difference in size and appearance of the nephrotomy site between preoperative and postoperative visual scintigraphic evaluations. Quantitative data did not reveal any significant difference between kidneys with and without a nephrotomy incision (p>0.05), as well as between nephrotomy regions and intact parenchyma within the same kidney (p>0.05) 3 months after nephrolithotomy. There was no significant difference in serum BUN and creatinine levels between values preoperatively and 3 months postoperatively (p>0.05).

Conclusions

There was no significant change in renal cortical function and functioning renal parenchymal mass after nephrolithotomy as shown by serum BUN and creatinine levels, and ^99mtechnetium dimercapto-succinic acid scintigraphy.     

The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones

We reviewed 53 patients with infection stones treated by extracorporeal shock wave lithotripsy (ESWL*) monotherapy to determine the long-term rate free of stones and the stone recurrence rate as correlated with the pre-treatment stone burden and the radiological presence of sand or fragments after the procedure. Long-term followup (mean 26.6 months) was available on 33 patients representing 38 kidneys. Although only 3 kidneys were free of stones immediately after ESWL, 20 were without stones at 3 months and 18 (47%) were stone-free at followup. Of 9 kidneys with fragments of more than 5 mm. after the final treatment 7 (78%) had residual fragments at 3 months and experienced stone progression. Of 9 kidneys with sand remaining 6 (66%) and all 3 kidneys that appeared to be free of stones after ESWL were without stones at followup. The 3-month plain film of the kidneys, ureters and bladder was a reliable indicator of eventual outcome. Of 20 kidneys that were free of stones at 3 months 16 remained without stones. Of 18 kidneys with residual stone particles at 3 months 14 showed disease progression, 2 had stable disease and 2 passed residual sand. Only 1 of 17 patients who were free of stones or had stable stone disease had a positive urine culture at followup. Patients with infection stone fragments 3 months after ESWL monotherapy have a high rate of stone progression (78%) and should undergo further treatment. ESWL monotherapy of infection stones requires close patient followup to assure that all residual fragments have passed and urine remains sterile.     

Supranormal renographic differential renal function in congenital hydronephrosis: fact, not artifact

PURPOSE: Children with unilateral hydronephrosis, who had been prospectively examined with diethylenetriaminepentaacetic acid (DTPA) and dimercapto-succinic acid (DMSA) renography, were evaluated to determine whether supranormal renographic differential renal function exists. MATERIALS AND METHODS: A total of 54 children with congenital single system hydronephrosis underwent abdominal ultrasound, voiding cystourethrogram, and DTPA and DMSA renal scans. None had abnormalities of the bladder or contralateral kidney. Differential renal function greater than 55% was defined as supranormal. RESULTS: Of the 54 patients 15 (28%) with a median age of 4 months (range 0.5 to 66) were identified with supranormal renographic renal function on either DTPA or DMSA. Supranormal renographic renal function was detected by DMSA in 9 cases (mean 57+/-2%), DTPA in 8 (mean 58+/-2%) and both in 2 (mean 57+/-2%). Average function demonstrated in the 15 patients was 55+/-3% (range 51 to 62) with DMSA which was not different from that found with DTPA (mean 55+/-4%, range 46 to 61%). The kidneys with supranormal renographic renal function were significantly larger than hydronephrotic controls according to longitudinal parenchymal area on DMSA. Mean followup was 20 months for 13 patients, with 8 of 13 (62%) undergoing pyeloplasty. Followup DTPA renal scans available in 9 children revealed persistent supranormal function in 6, despite pyeloplasty in 3. CONCLUSIONS: Supranormal renographic differential renal function does exist in congenital hydronephrosis and when found the kidneys are consistently enlarged. The position of supranormal renographic renal function in the management algorithm of hydronephrosis remains to be elucidated as it does not appear to be a benign prognostic factor.     

Assessing the efficiency of extracorporeal shockwave lithotripsy for stones in renal units with impaired function: a prospective controlled study

The objective was to determine the efficiency of extracorporeal shockwave lithotripsy (ESWL) in clearing stones from renal units with impaired function. Thirty-five patients with poorly functioning kidneys determined by intravenous urogram and ^99mtechnetium diethylene triamine pentacetic acid renal dynamic scan underwent ESWL. Stone clearance was assessed at 3 months and compared with that in normally functioning kidneys. The study group was divided into two subgroups. Those with split glomerular filtration rate (GFR) of the concerned kidney between 10 and 20 ml/min were in group 1. Group 2 consisted of patients with split GFR between 20 and 30 ml/min. A control group (group 3) was formed from patients with urolithiasis and normally functioning kidneys. The overall retreatment rate was 84.4%. The overall stone clearance rate in the study group was 34.2% while it was 57.7% in the control group. The stone clearance rate in group 2 was 40%. The difference in stone clearance rate between the study and control groups was statistically significant (P=0.023) but that between group 2 and the control group was not (P=0.159). The incidence of steinstrasse between the study group 2 and control group was not statistically significant (P=0.408). The clearance rate for ureteral stones was comparable in all the three groups. The stone-free rate and rate of steinstrasse for renal stones in kidneys with moderately impaired function were comparable to normally functioning kidneys. However, kidneys with severely impaired function had poor results. The clearance rate for ureteral stones was not influenced by the impairment of renal function.     

一期输尿管软镜联合经皮肾镜治疗鹿角形结石合并脓肾的疗效和安全性

目的探讨一期输尿管软镜(FURS)联合经皮肾镜取石术(PCNL)治疗鹿角形结石合并脓肾的可行性、有效性和安全性。方法回顾性分析北京大学第三医院2017年5月至2019年12月采用一期FURS联合PCNL治疗的13例鹿角形结石合并脓肾患者的病例资料,男7例,女6例。年龄52.5(33~68)岁。临床表现为间断发热9例,腰部不适6例,肉眼血尿1例,2例无明显临床表现。8例合并糖尿病。CT检查示完全型鹿角形结石6例,部分型7例;结石位于左侧7例,右侧6例;4例伴中/重度肾积水,9例伴轻度肾积水。影像学检查评估结石负荷(1070.9±397.0)(507.4~1809.5)mm^2。13例术前均行尿细菌培养及药敏试验。4例住院时有发热症状者术前留置患侧输尿管支架管≥1周。所有病例术前应用抗菌药物≥1周,待感染症状及感染相关指标恢复正常后接受手术治疗。手术采用全麻,患者取改良Valdivia体位。先经尿道置入FURS到达患侧肾盂,B超及FURS引导下在患侧腋中线和肩胛旁线之间、12肋下建立经皮肾标准通道,单通道PCNL下采用负压吸引装置吸出脓液并处理视野范围内的结石,再联合FURS处理其他肾盏结石。术中PCNL穿刺成功后,均可见肾内浑浊脓性尿液排出,留取肾内尿液送检细菌培养及药敏试验。本组13例均经术中肾盂尿细菌培养结果确诊为脓肾。术后常规留置输尿管支架管和肾造瘘管,继续抗感染治疗。术后第1~3天行影像学检查,评估结石清除率,残留结石≥4 mm为有意义的结石残留。结果本组13例手术均顺利完成,手术时间(94.2±21.8)(65~135)min。一期结石清除率76.9%(10/13)。术后6例出现全身炎症反应综合征,无脓毒血症及≥Clavien-DindoⅢ级并发症发生。术后中位随访12(3~24)个月,4例患侧结石复发,2例患侧轻度肾萎缩,随访期间无患侧上尿路感染复发。结论FURS联合PCNL是治疗鹿角形结石合并脓肾的有效方法,具有良好的疗效和安全性。     

Paediatric percutaneous nephrolithotomy: setting new frontiers

OBJECTIVE: To assess the safety and outcome of paediatric percutaneous nephrolithotomy (PCNL) for atypical cases and compare the results with 'standard' unilateral paediatric PCNL. PATIENTS AND METHODS: We retrospectively reviewed children who had had a PCNL between December 1997 and December 2004. Patients were grouped as follows: group 1, aged >5-16 years with normal anatomy and normal renal function undergoing unilateral PCNL or staged bilateral PCNL; group 2, < or = 5 years with normal anatomy and renal function undergoing unilateral PCNL; group 3, undergoing bilateral simultaneous PCNL; group 4, impaired renal function in addition to renal stone disease; group 5, renal anatomical abnormality with calculi in the same kidney. Demographics, stone profile, procedure and outcome indicators were analysed for each group. RESULTS: In all, 188 consecutive PCNLs in 169 children were included (mean age 3.3-10.3 years, mean stone burden 19.1-33.3 mm in the five groups). The mean duration of PCNL was 69-115 min. Stone clearance was satisfactory with single tract access in 90-100% of patients. Transient postoperative fever was the commonest complication (12.5-51%) followed by hyponatraemia and hypokalaemia. Blood transfusion was required in 0-7.7%. The mean stone clearance rates were 47-90% in the five groups; additional extracorporeal shockwave lithotripsy increased the cumulative clearance rates to 90-100%. CONCLUSION: PCNL is safe for treating renal stones, with excellent results and minimal complications. Comparable results are achieved in the very young child, children with anatomically abnormal kidneys, children with impaired renal function and children with bilateral renal stones undergoing simultaneous bilateral PCNL. Hence none of these factors should be considered as relative contraindications.     

Short-term effect of a new portable extracorporeal lithotripter on renal function

Extracorporeal shock wave lithotripsy has become the treatment of choice for upper urinary tract stones. We evaluated the impact of a new lithotripter on the kidneys of 14 nonobstructed patients treated for renal stones, using several physiological parameters and renal ultrasonography. Glomerular filtration rates (GFR) were estimated from the renal scan. Complete disintegration of the stone was accomplished in all but one patient. Treatment did not alter the serum parameters or the renal ultrasonography. Also, no changes were found in the GFR on the follow-up renal scans in both kidneys. The implications of these findings are discussed.     

sup 99m TECHNETIUM-DIMERCAPTO-SUCCINIC ACID RENAL SCAN IN THE EVALUATION OF POTENTIAL LONG-TERM RENAL PARENCHYMAL DAMAGE ASSOCIATED WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN CHILDREN

Purpose

Extracorporeal shock wave lithotripsy (ESWL ^†) has been reported as efficient and safe in children. Because of reports of renal parenchymal damage in adults, this study was designed to assess the effects of ESWL in pediatric kidneys evaluated before and after treatment with^99m technetium dimercapto-succinic acid (DMSA) renal scan.

Materials and Methods

A total of 15 children, 9 months to 15 years old (mean age 6.5 years), underwent ESWL treatment for urolithiasis. Evaluation imaging included plain abdominal radiography, excretory urogram and/or renal sonography. DMSA renal scan was performed 24 hours before ESWL and at least 6 months after treatment.

Results

ESWL was performed in 1 session for 8 patients, 2 sessions for 6 and 3 sessions for 1, delivering a range of 600 to 3,000 shock waves per session. Treatment was successful in achieving stone-free status in 87% of the cases. Long-term followup (1 to 5 years) showed no blood pressure changes. On DMSA renal scan no acquired parenchymal scar was identified at least 6 months after ESWL treatment.

Conclusions

The efficacy of ESWL in treating pediatric urolithiasis is confirmed. Renal parenchymal trauma associated with ESWL does not appear to cause long-term lesions identifiable by DMSA renal scan.     

以肾中盏为目标肾盏行气压弹道联合超声碎石治疗鹿角形结石的效果及安全性

目的：探讨以肾中盏为目标肾盏,采用气压弹道联合超声碎石方式治疗鹿角形结石的效果及安全性。方法：取俯卧位,采用气压弹道联合超声碎石的方式,以肾中盏为目标肾盏行经皮肾镜碎石术（percutaneous nephrolithotomy,PCNL）治疗鹿角形结石患者145例184侧,其中不完全性鹿角形结石115例侧,完全性鹿角形结石69例侧。观察结石的排除率及并发症。结果：144例侧行一期单通道碎石（中盏）,7例侧行一期双通道碎石（中盏及下盏5例,中盏及上盏2例）;2例侧残留肾盏结石未进一步处理,自动出院;31例侧行二期碎石,单通道者29例,其中4例先行ESWL再行PCNL碎石;双通道者2例（中盏及上盏1例,中盏及下盏1例）。151例侧排尽结石,其中完全性鹿角形结石54例侧,不完全性鹿角形结石97例侧,结石清除率82．1％。手术时间120～330min,平均（147±23）min。血红蛋白下降1～4g／L,平均下降（2．0±0．6）g／L,术中输血22例,术后输血5例;术后肾盂内感染3例,合并肾周感染、单侧分肾功能受损1例。平均住院时间（13．0±3．5）天。结论：以肾中盏为目标肾盏行PCNL治疗鹿角形结石是非常有效和安全的;气压弹道联合超声碎石对鹿角性结石的清除率较高,治疗时问短,并发症少。